Publication pilot GIPS-IV study

https://www.hindawi.com/journals/jitc/2020/6014915/

Recently, the results of our pilot study were published. We investigated the safety and tolerability in patients presenting with acute coronary syndrome. Our results suggest that sodium thiosulfate is well tolerated in this setting.

Currently, the efficacy of sodium thiosulfate in STEMI setting is being investigated in the GIPS-IV trial.